Blood coagulation factor inhibitors
US8486892B2 · kind B2 · utility
1Cited by
0References
34Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 22, 2009 |
| Grant date | Jul 16, 2013 |
| Priority date | — |
| Expiry date | Sep 12, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K5/1019
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel compounds with formula (I) X1-X2-X3-X4-X5-(X6)n-(X7)m-Y useful as blood coagulation factor inhibitors. The compounds (I) may be used for treatment of thrombotic conditions or as stabilizers of liquid formulations of blood coagulation factors, in particular liquid formulations of FVIIa, Factor VII variants, or Factor VII derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.